MK-677 (Ibutamoren)
Orally active ghrelin mimic. It binds to the GHS-R1a receptor in the brain, increasing the pulsatile release of GH without affecting cortisol (except at first).
- Sustained increase in basal IGF-1
- Improved sleep (REM)
- Increased lean mass/nitrogen retention
- Improved hair and skinSustained increase in basal IGF-1
- Improved hair and skin
- Insulin resistance (raises glucose).
- Severe water retention (oedema).
- Hunger/Lethargy.
- Fear of anxiety.Insulin resistance (raises glucose).
- Fear of anxiety.
MK-677 (Ibutamoren) is not a peptide, but a long-acting oral ghrelin receptor agonist and a potent growth hormone secretagogue.
READ MORE
What it is (in plain language)
- It's a substance taken orally that tricks the brain into thinking the body is hungry (via ghrelin). This causes a massive, pulsatile release of Growth Hormone (GH) and IGF-1, without interfering with natural testosterone.
Why do you appear online so much
- It's a favourite for those who want the benefits of GH without needles. It helps with deep sleep, appetite for mass gain and recovery. It's very common in bulking cycles due to the drastic increase in appetite it causes.
How it is framed today (pragmatic view)
- 1) Evidence: Widely studied for sarcopenia and GH deficiencies. 2) Goal: Increase lean mass, bone density and sleep quality. 3) Risk: May increase insulin resistance and cause water retention; glycaemia should be monitored.
How to use this form
- See the 'Interactions' section to learn how to mitigate the increase in prolactin and blood sugar spikes.
- Quick profile (curated by Subject 157)
- Class: Hormonal
- Status: Verified
- Use case: Muscle Growth
- Route: Oral
- Tags: Oral|GH|Bulking
- Half-life: ~24 Hours
- Start: Slow
- Duration: 24 hours
- Mechanism (high level)
Orally active ghrelin mimic. It binds to the GHS-R1a receptor in the brain, increasing the pulsatile release of GH without affecting cortisol (except at first).
- Evidence (what the literature covers)
RESEARCH RANGE (Geriatrics, Non-prescriptive):
Long studies (2 years) in the elderly.
Level of Evidence: A.
- Safety and harm-reduction (non-prescriptive)
Risks: Insulin resistance (raises glucose).
Severe water retention (oedema).
Hunger/Lethargy.
Fear of anxiety.
Interactions: Berberine/Metformin (for glucose control).
- References (anchors)
- Nass, R. (2008) - Effects of an oral ghrelin mimetic on body composition - https://doi.org/10.7326/0003-4819-149-9-200811040-00003
- PubMed:18981485
Note: Educational/research content. Does not constitute medical advice, diagnosis or prescription.
